Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The proposed study is an open-label, single-center, single arm phase 1b study to evaluate the
safety and efficacy of radiotherapy plus sintilimab for HCC with PVTT.